Zurich / Glattbrugg | Cytosurge AG, a Swiss company that develops, manufactures and distributes scientific high-precision nanotechnology instruments and robotic systems based on its patented FluidFM® technology, and Bruker Corporation, one of the world’s leading analytical instrumentation companies, have entered into a new partnership. Thanks to this Premium partnership, researchers can combine the femtoliters scale fluid control […]
ALAMEDA, Calif.–BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on degenerative diseases, today announced that it has been awarded a grant of $743,345 from the Small Business Innovation Research (SBIR) program of the National Institutes of Health (NIH). This award constitutes the second-year funding of a $1.6 million SBIR grant to advance BioTime’s innovative, next generation retinal restoration program addressing advanced retinal diseases […]
Since the groundbreaking discovery of human induced pluripotent stem cells (hiPSCs) by Shinya Yamanaka in 2006, the use of pluripotent stem cells (PSCs) has experienced a boom. Due to their extensive in vitro self-renewal properties and their ability to differentiate into many different cell types, PSCs, and especially hiPSCs, offer exciting promises in a wide […]
Symcel appoints two new board members to bolster R&D business growth and expansion into the clinical diagnostics market L: Stefan LöfÃ¥s, R: Erik Walldén Symcel – the company behind the revolutionary cell-based assay tool for real-time cell metabolism measurements, the calScreenerâ„¢ – has announced the appointment of two new highly experienced board members; Erik Walldén and […]
Sysmex Corporation (HQ: Kobe, Japan: Chairman and CEO: Hisashi Ietsugu), the Foundation for Biomedical Research and Innovation at Kobe1Â (Location: Kobe, Japan; President: Tasuku Honjo) and Kyoto University (Location: Kyoto, Japan; President: Juichi Yamagiwa) have begun joint research related to the Drug Discovery Innovation Program2: Developing Technologies for Diagnosing Immunological Diseases, which the Foundation is promoting. […]
Berkeley Lights and ChemPartner Collaborate on Accelerating Antibody Discovery Emeryville, Calif. Berkeley Lights, Inc. (BLI), a leader in digital cell biology, announced today that it has entered into a collaboration with ChemPartner Co., Ltd. (ChemPartner) focused on accelerating ChemPartner’s monoclonal antibody (mAb) discovery workflow utilizing the Beacon®Optofluidic platform. The goal is to expand ChemPartner’s antibody discovery […]
Program will Aim to Further Characterize the Functional Impact of Nektar Immunotherapies BRANFORD, Conn. — IsoPlexis Corporation (IsoPlexis), a privately held life sciences company at the forefront of single-cell analytics technology, announced today its collaboration with Nektar Therapeutics. The collaboration is focused on further defining the functional impact of NKTR-214 in the clinic, at the single-cell level, […]
S2 Genomics will develop the Singulatorâ„¢ system for automated preparation of single cells or nuclei from solid tissue samples LIVERMORE, Calif.–S2 Genomics, Inc. has received a $280,000 Phase I STTR grant (1 R41 HG010129-01) from the National Institutes of Health’s National Human Genome Research Institute to develop the Singulatorâ„¢ system for automated preparation of single […]
Brussels – Ovizio Imaging Systems, a life science imaging technology company, announces the appointment of Emilie Viey as CEO and board member. Dr. Viey will lead Ovizio’s further development as solution provider for imaging applications in Life Sciences. Emilie Viey joins Ovizio Imaging Systems from ACEA Biosciences, a Cell Analysis instruments company based in San Diego […]
AMSBIO announces MyEZGelâ„¢ 3D-iPSC Matrix – a powerful new tool for in vitro 3D human induced pluripotent stem cell (hiPSC) culture, enabling more accurate in vivo predictions in life science research and development. MyEZGelâ„¢ 3D-iPSC is a synthetic xeno-free hydrogel matrix inspired by muscle and spider silk proteins. Beneficially, MyEZGelâ„¢ is proven to overcome basic […]
Pay Invoice
Latest Blogs
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
